GLENWOOD, Ill., Aug. 26, 2015 /PRNewswire/ -- Landauer,
Inc. (NYSE: LDR), a recognized leader in personal and
environmental radiation measurement and monitoring, outsourced
medical physics services and high quality medical consumable
accessories, today announced that its Board of Directors has
elected Michael P. Kaminski to
succeed Michael T. Leatherman as
President and Chief Executive Officer of the Company, effective
October 1, 2015. Mr. Kaminski has
also been appointed to the company's Board of Directors, effective
the same date. Mr. Kaminski currently serves as President of
Landauer's Radiation Measurement business.
In addition, the Board of Directors appointed Mr. Leatherman to
the role of Executive Chairman of the Board of Directors and
announced that Robert Cronin,
Landauer's current Chairman, will become the Board's Lead
Independent Director, both effective October
1, 2015.
Mr. Leatherman said, "It has been an honor to lead Landauer, and
I'm proud of the progress the company has made on its growth
initiatives. We are well positioned as the leading provider of
enterprise-wide radiation management solutions and poised to
capitalize on the significant market opportunities ahead.
Over the past few years, Mike
Kaminski has been critical to our efforts, and I look
forward to continuing to support Mike and the rest of our
outstanding team as the company builds on its strong platform for
future growth."
Mr. Cronin stated, "We have a highly skilled and seasoned
executive in Mike Kaminski, with a
demonstrated track record and a deep understanding of our business
and our customers. During his tenure, Mike has made exceptional
contributions to Landauer, including driving innovation and market
development, implementing lean processes and positioning our
Radiation Measurement business as an engine for future growth.
We are confident in Mike's ability to lead the company
forward and execute on our plan for sustainable growth."
Cronin continued, "On behalf of the Board, I would also like to
thank Mike Leatherman for his
tremendous leadership during an important time for the
company. It has been a pleasure to work with him, and we look
forward to continuing to benefit from his strategic counsel in his
new role as Executive Chairman."
Mr. Kaminski stated, "I am excited to have the opportunity to
lead this outstanding organization, and I look forward to
continuing to work with Mike
Leatherman in his new role as well as with our entire
management team and talented professionals around the world. Today,
we are successfully executing on our key initiatives and are well
positioned to meet the emerging needs for a broader radiation
management solution. We continue to see strong demand for our
solutions and believe we have the right plan in place to leverage
Landauer's unique market position and drive significant growth and
long-term value for shareholders."
Mr. Kaminski, 55, joined Landauer in April 2013 as President of the Radiation
Measurement Division, the company's largest business
segment. Prior to joining Landauer, Mr. Kaminski was the
President and CEO of Stereotaxis, a medical robotic
company. Before Stereotaxis, Mr. Kaminski spent nearly 20
years at Hill-Rom Inc. where he held several functional positions,
including sales, service, marketing, and operations. He also
served in key executive leadership positions, which included
general management of the hospital business. During Mr. Kaminski's
tenure at Hill-Rom, the company grew from $100M to over $1.1B
in revenue.
About Landauer
Landauer is a leading global provider of technical and
analytical services to determine occupational and environmental
radiation exposure, the leading domestic provider of outsourced
medical physics services, as well as a provider of high quality
medical accessories used in radiology, radiation therapy, and image
guided surgery procedures. For more than 50 years, the Company has
provided complete radiation dosimetry services to hospitals,
medical and dental offices, universities, national laboratories,
nuclear facilities and other industries in which radiation poses a
potential threat to employees. Landauer's services include the
manufacture of various types of radiation detection monitors, the
distribution and collection of the monitors to and from customers,
and the analysis and reporting of exposure findings. The Company
provides its dosimetry services to approximately 1.8 million
individuals globally. In addition, through its Medical Physics
segment, the Company provides therapeutic and imaging physics
services to the medical physics community. Through its Medical
Products segment, the Company provides medical consumable
accessories used in radiology, radiation therapy, and image guided
surgery procedures. For information about Landauer, please visit
their website at http://www.landauer.com.
Safe Harbor Statement
Some of the information shared here constitutes forward-looking
statements that are based on assumptions and involve certain risks
and uncertainties. These include the following, without limitation:
assumptions, risks and uncertainties associated with the Company's
future performance; the Company's development and introduction of
new technologies in general; the ability to protect and utilize the
Company's intellectual property; continued customer acceptance of
the InLight technology; the adaptability of optically stimulated
luminescence (OSL) technology to new platforms and formats;
military and other government funding for the purchase of certain
of the Company's equipment and services; the impact on sales and
pricing of certain customer group purchasing arrangements; changes
in spending or reimbursement for medical products or services; the
costs associated with the Company's research and business
development efforts; the usefulness of older technologies and
related licenses and intellectual property; the effectiveness of
and costs associated with the Company's IT platform enhancements;
the anticipated results of operations of the Company and its
subsidiaries or ventures; valuation of the Company's long-lived
assets or business units relative to future cash flows; changes in
pricing of services and products; changes in postal and delivery
practices; the Company's business plans; anticipated revenue and
cost growth; the ability to integrate the operations of acquired
businesses and to realize the expected benefits of acquisitions;
the risks associated with conducting business internationally;
costs incurred for potential acquisitions or similar transactions;
other anticipated financial events; the effects of changing
economic and competitive conditions, including instability in
capital markets which could impact availability of short and
long-term financing; the timing and extent of changes in interest
rates; the level of borrowings; foreign exchange rates; government
regulations; accreditation requirements; changes in the trading
market that affect the costs of obligations under the Company's
benefit plans; and pending accounting pronouncements. These
assumptions may not materialize to the extent assumed, and risks
and uncertainties may cause actual results to be different from
what is anticipated today. These risks and uncertainties also may
result in changes to the Company's business plans and prospects,
and could create the need from time to time to write down the value
of assets or otherwise cause the Company to incur unanticipated
expenses. Additional information may be obtained by reviewing the
information set forth in Item 1A "Risk Factors" and Item 7A
"Quantitative and Qualitative Disclosures about Market Risk" and
information contained in the Company's Annual Report on
Form 10-K for the year ended September 30, 2014 and other
reports filed by the Company, from time to time, with the
Securities and Exchange Commission. The Company does not undertake,
and expressly disclaims, any duty to update any forward-looking
statement whether as a result of new information, future events or
changes in the Company's expectations, except as required by
law.
For Further Information Contact:
Michael DeGraff
Sard Verbinnen &
Co
Phone: 312.895.4734
Email:
mdegraff@sardverb.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/landauer-inc-names-mike-kaminski-president-and-chief-executive-officer-effective-october-1-300133733.html
SOURCE Landauer, Inc.